Ageing blood vessels may weaken immune defences in late-stage COPD

A new study has uncovered a key link between ageing blood vessel cells and weakened immune responses in late-stage chronic obstructive pulmonary disease (COPD). Published in Cell Death Discovery, the research shows how senescent endothelial cells disrupt T cell function, worsening immune defence in the lungs. The findings point to potential treatments that could restore immune activity in patients with advanced disease.

The study focused on how endothelial cells—the cells lining blood vessels—change as they age in COPD patients. Researchers used primary human lung samples and multi-omic analyses to track these changes. Their results revealed that senescent endothelial cells release factors that create an environment suppressing immune function.

In advanced COPD, these ageing cells were found to directly impair T cells, a type of immune cell critical for fighting infections. The T cells became exhausted and produced fewer cytokines, molecules essential for a strong immune response. This immune dysfunction grew worse as endothelial senescence accumulated over time. The research did not include a specific patient count from a study by Lee, Kim, and Song, as the available data lacked these details. However, the findings still highlight a progressive decline in immune function tied to cell ageing in the lungs. Scientists now suggest that targeting senescent endothelial cells could offer a new way to treat COPD. Drugs that clear these ageing cells (senolytics) or modify their behaviour (senomorphics) might help restore T cell activity. This approach could improve outcomes for patients with severe disease.

The study provides clear evidence that endothelial cell ageing plays a central role in immune decline during late-stage COPD. By focusing on cellular senescence, future treatments could potentially reverse immune dysfunction and slow disease progression. Further research may also explore how smoking or pollution accelerate this process in vulnerable patients.